Late outgrowth endothelial progenitor cells engineered for improved survival and maintenance of function in transplant-related injury

Transplant International

Volumn 25, Issue 2, 2012, Pages 229-241

  Zhao, Jing ^a   Bolton, Eleanor M ^a   Ormiston, Mark L ^a   Bradley, J Andrew ^a   Morrell, Nicholas W ^a   Lever, Andrew M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

A20; gene transfer; inflammation; ischaemia reperfusion injury; late outgrowth endothelial progenitor cells; transplant vasculopathy

Indexed keywords

CASPASE 3; CELL ADHESION MOLECULE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; APOPTOSIS; ARTICLE; CELL ENGINEERING; CELL GROWTH; CELL SURVIVAL; CYTOKINE RELEASE; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TRANSPLANTATION; UPREGULATION; VASCULAR SURGERY;

APOPTOSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; GRAFT REJECTION; HUMANS; ORGAN TRANSPLANTATION; REPERFUSION INJURY; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR DISEASES;

EID: 84856023572     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01387.x     Document Type: Article

References (58)

1. Kwun J, Knechtle SJ,. Overcoming chronic rejection-can it B? Transplantation 2009; 88: 955.
2. Wehner J, Morrell CN, Reynolds T, Rodriguez ER, Baldwin 3rd WM,. Antibody and complement in transplant vasculopathy. Circ Res 2007; 100: 191.
3. Xiao Q, Kiechl S, Patel S, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis - results from a large population-based study. PLoS ONE 2007; 2: e975.
4. Zampetaki A, Kirton JP, Xu Q,. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008; 78: 413.
5. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981.
6. Choi J-H, Kim KL, Huh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246.
7. Urbich C, Dimmeler S,. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005; 67: 1672.
8. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: e1.
9. Kong D, Melo LG, Gnecchi M, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039.
10. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457.
11. Karra R, Vemullapalli S, Dong C, et al. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci USA 2005; 102: 16789.
12. Hu Y, Davison F, Zhang Z, Xu Q,. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 2003; 108: 3122.
13. Xu Q, Zhang Z, Davison F, Hu Y,. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003; 93: e76.
14. de Groot K, Bahlmann FH, Bahlmann E, Menne J, Haller H, Fliser D,. Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation 2005; 79: 941.
15. Soler MJ, Martinez-Estrada OM, Puig-Mari JM, et al. Circulating endothelial progenitor cells after kidney transplantation. Am J Transplant 2005; 5: 2154.
16. Steiner S, Winkelmayer WC, Kleinert J, et al. Endothelial progenitor cells in kidney transplant recipients. Transplantation 2006; 81: 599.
17. Sathya CJ, Sheshgiri R, Prodger J, et al. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients. Transpl Int 2010; 23: 641.
18. Woywodt A, Schroeder M, Gwinner W, et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 2003; 76: 1.
19. Rabelink TJ, de Boer HC, de Koning EJ, van Zonneveld AJ,. Endothelial progenitor cells: more than an inflammatory response? Arterioscler Thromb Vasc Biol 2004; 24: 834.
20. Liu JW, Dunoyer-Geindre S, Blot-Chabaud M, et al. Generation of human inflammation-resistant endothelial progenitor cells by A20 gene transfer. J Vasc Res 2010; 47: 157.
21. Zhang Y, Ingram DA, Murphy MP, et al. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2009; 296: H1675.
22. Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362.
23. Heyninck K, Beyaert R,. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 2005; 30: 1.
24. Daniel S, Arvelo MB, Patel VI, et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 2004; 104: 2376.
25. Zhao J, Pettigrew GJ, Bolton EM, et al. Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection. Gene Ther 2005; 12: 1509.
26. Zhao J, Bolton EM, Bradley JA, Lever AM,. Lentiviral-mediated overexpression of Bcl-xL protects primary endothelial cells from ischemia/reperfusion injury-induced apoptosis. J Heart Lung Transplant 2009; 28: 936.
27. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA,. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 1995; 14: 2876.
28. Baeuerle PA, Baltimore D,. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540.
29. Beg AA, Baltimore D,. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274: 782.
30. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM,. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996; 274: 787.
31. Ko Y, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H,. Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. Mol Cell Probes 1999; 13: 203.
32. Marsboom G, Janssens S,. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Expert Rev Cardiovasc Ther 2008; 6: 687.
33. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801.
34. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964.
35. Dimmeler S, Zeiher AM,. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000; 87: 434.
36. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593.
37. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752.
38. Sieveking DP, Buckle A, Celermajer DS, Ng MK,. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008; 51: 660.
39. Urbich C, Dimmeler S,. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343.
40. Rehman J, Li J, Orschell CM, March KL,. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164.
41. Zhang SJ, Zhang H, Wei YJ, et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 2006; 16: 577.
42. Asakage M, Tsuno NH, Kitayama J, et al. Early-outgrowth of endothelial progenitor cells can function as antigen-presenting cells. Cancer Immunol Immunother 2006; 55: 708.
43. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP,. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71.
44. Ingram DA, Caplice NM, Yoder MC,. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525.
45. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC,. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005; 105: 2783.
46. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422.
47. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009.
48. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427.
49. Torras J, Cruzado JM, Grinyo JM,. Ischemia and reperfusion injury in transplantation. Transplant Proc 1999; 31: 2217.
50. Maxwell SR, Lip GY,. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997; 58: 95.
51. Duchen MR,. Roles of mitochondria in health and disease. Diabetes 2004; 53 (Suppl. 1): S96.
52. Ferrari R, Cargnoni A, Bernocchi P, et al. Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. Circulation 1996; 94: 2587.
53. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430.
54. He T, Peterson TE, Holmuhamedov EL, et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004; 24: 2021.
55. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S,. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004; 104: 3591.
56. Ingram DA, Krier TR, Mead LE, et al. Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 2007; 25: 297.
57. Cailhier JF, Laplante P, Hebert MJ,. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am J Transplant 2006; 6: 247.
58. Heyninck K, De Valck D, Vanden Berghe W, et al. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol 1999; 145: 1471.